PEGylated bile acids for use in drug delivery systems: Enhanced solubility and bioavailability of itraconazole

Molecular Pharmaceutics

Volumn 10, Issue 8, 2013, Pages 3057-3066

  Le Dévédec, Frantz ^a   Strandman, Satu ^a   Hildgen, Patrice ^a   Leclair, Grégoire ^a   Zhu, X X ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

itraconazole; PEGylated bile acids; self emulsifying drug delivery systems

Indexed keywords

BILE ACID; CHOLIC ACID; DEOXYCHOLIC ACID; ITRACONAZOLE; LITHOCHOLIC ACID; OLEIC ACID; PEGYLATED BILE ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; AQUEOUS SOLUTION; ARTICLE; CELL STRAIN CACO 2; CHEMICAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; EMULSION; ERYTHROCYTE; FOURIER TRANSFORMATION; HEMOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDRODYNAMICS; INFRARED SPECTROSCOPY; INTESTINE ABSORPTION; LIGHT SCATTERING; LIQUID; MICELLE; MYCOSIS; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; RAT; SELF EMULSIFYING DRUG DELIVERY SYSTEM; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

ANIMALS; BILE ACIDS AND SALTS; BIOLOGICAL AVAILABILITY; CACO-2 CELLS; DRUG DELIVERY SYSTEMS; HUMANS; ITRACONAZOLE; MALE; POLYETHYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY;

EID: 84881353953     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400117m     Document Type: Article

References (51)

1. Boogaerts, M.; Maertens, J. Clinical experience with itraconazole in systemic fungal infections Drugs 2001, 61, 39-47
2. De Beule, K.; Van Gestel, J. Pharmacology of itraconazole Drugs 2001, 61, 27-37
3. Six, K.; Verreck, G.; Peeters, J.; Binnemans, K.; Berghmans, H.; Augustijns, P.; Kinget, R.; Van den Mooter, G. Investigation of thermal properties of glassy itraconazole: identification of a monotropic mesophase Thermochim. Acta 2001, 376, 175-181
4. Pardeike, J.; Weber, S.; Haber, T.; Wagner, J.; Zarfl, H. P.; Plank, H.; Zimmer, A. Development of an Itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application Int. J. Pharmaceutics 2011, 419, 329-338
5. Peeters, J.; Neeskens, P.; Tollenaere, J. P.; Van Remoortere, P.; Brewster, M. E. Characterization of the interaction of 2-hydroxypropyl-β- cyclodextrin with itraconazole at pH 2, 4, and 7 J. Pharm. Sci. 2002, 91, 1414-1422
6. Fromtling, R. A. Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents; J. R. Prous Science Publishers: Barcelona, Spain, 1987; pp 233-249.
7. Thomson, P. D. R. Physician's Desk Reference; PDR Network: Montvale, NJ, 2005; pp 1757-1766.
8. Kim, J.-K.; Park, J.-S.; Kim, C.-K. Development of a binary lipid nanoparticles formulation of itraconazole for parenteral administration and controlled release Int. J. Pharmaceutics 2010, 383, 209-215
9. Chen, W.; Gu, B.; Wang, H.; Pan, J.; Lu, W.; Hou, H. Development and evaluation of novel itraconazole-loaded intravenous nanoparticles Int. J. Pharmaceutics 2008, 362, 133-140
10. Yi, Y.; Yoon, H. J.; Kim, B. O.; Shim, M.; Kim, S.-O.; Hwang, S.-J.; Seo, M. H. A mixed polymeric micellar formulation of itraconazole: Characteristics, toxicity and pharmacokinetics J. Controlled Release 2007, 117, 59-67
11. Neslihan Gursoy, R.; Benita, S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs Biomed. Pharmacother. 2004, 58, 173-182
12. Tang, J.-L.; Sun, J.; He, Z.-G. Emulsifying drug delivery systems: strategy for improving oral delivery of poorly soluble drugs Curr. Drug Ther. 2007, 2, 85-93
13. Hong, J.-Y.; Kim, J.-K.; Song, Y.-K.; Park, J.-S.; Kim, C.-K. A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption J. Controlled Release 2006, 110, 332-338
14. Woo, J. S.; Song, Y.-K.; Hong, J.-Y.; Lim, S.-J.; Kim, C.-K. Reduced food-effect and enhanced bioavailability of a self-microemulsifying formulation of itraconazole in healthy volunteers Eur. J. Pharm. Sci. 2008, 33, 159-165
15. Arias, I. M.; Boyer, J. L.; Fausto, N.; Jakoby, W. B.; Schachter, D. A.; Shafritz, D. A. In The Liver: Biology and Pathobiology, 3 rd ed.; Carey, M. C.; Duane, W. C., Eds.; Raven Press: New York, 1994.
16. Hofmann, A. F.; Small, D. M. Detergent Properties of Bile Salts: Correlation with Physiological Function Annu. Rev. Med. 1967, 18, 333-376
17. Small, D. M.; Nair, P. P.; Kritchevsky, D. The Bile Acids: Chemistry, Physiology and Metabolism; Plenum Press: New York, 1971; Vol. 2.
18. Helenius, A.; Simons, K. Solubilization of Membranes by Detergents Biochim. Biophys. Acta, Biomembr. 1975, 415, 29-79
19. Virtanen, E.; Kolehmainen, E. Use of Bile Acids in Pharmacological and Supramolecular Applications Eur. J. Org. Chem. 2004, 2004, 3385-3399
20. Marples, B. A.; Stretton, R. J. Use of Steroidal Compounds as Anti-fungal Agents. WO 9013298, 1990.
21. Luo, J.; GigueÌre, G.; Zhu, X. X. Asymmetric Poly(ethylene glycol) Star Polymers with a Cholic Acid Core and Their Aggregation Properties Biomacromolecules 2009, 10, 900-906
22. Le Dévédec, F.; Fuentealba, D.; Strandman, S.; Bohne, C.; Zhu, X. X. Aggregation Behavior of Pegylated Bile Acid Derivatives Langmuir 2012, 28, 13431-13440
23. Alam, S.; Iqbal, Z.; Ali, A.; Khar, R. K.; Ahmad, F. J.; Akhter, S.; Talegaonkar, S. Microemulsion as a Potential Transdermal Carrier for Poorly Water Soluble Antifungal Drug Itraconazole J. Dispersion Sci. Technol. 2009, 31, 84-94
24. Caliph, S. M.; Charman, W. N.; Porter, C. J. H. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats J. Pharm. Sci. 2000, 89, 1073-1084
25. Porter, C. J. H.; Charman, W. N. Intestinal lymphatic drug transport: an update Adv. Drug Delivery Rev. 2001, 50, 61-80
26. Yáñez, J. A.; Wang, S. W. J.; Knemeyer, I. W.; Wirth, M. A.; Alton, K. B. Intestinal lymphatic transport for drug delivery Adv. Drug Delivery Rev. 2011, 63, 923-942
27. Müller, R. H.; Mäder, K.; Gohla, S. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art Eur. J. Pharm. Biopharm. 2000, 50, 161-177
28. Six, K.; Verreck, G.; Peeters, J.; Augustijns, P.; Kinget, R.; Van den Mooter, G. Characterization of glassy itraconazole: a comparative study of its molecular mobility below Tg with that of structural analogues using MTDSC Int. J. Pharmaceutics 2001, 213, 163-173
29. Six, K.; Leuner, C.; Dressman, J.; Verreck, G.; Peeters, J.; Blaton, N.; Augustijns, P.; Kinget, R.; Van den Mooter, G. Thermal Properties of Hot-Stage Extrudates of Itraconazole and Eudragit E100. Phase separation and polymorphism J. Therm. Anal. Calorim. 2002, 68, 591-601
30. Shim, S.-Y.; Ji, C.-W.; Sah, H.; Park, E.-S.; Lee, B.-J. Characterization of itraconazole semisolid dosage forms prepared by hot melt technique Arch. Pharm. Res. 2006, 29, 1055-1060
31. Brouwers, J.; Brewster, M. E.; Augustijns, P. Supersaturating drug delivery systems: The answer to solubility-limited oral bioavailability? J. Pharm. Sci. 2009, 98, 2549-2572
32. Shah, N. H.; Carvajal, M. T.; Patel, C. I.; Infeld, M. H.; Malick, A. W. Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs Int. J. Pharmaceutics 1994, 106, 15-23
33. Tarr, B. D.; Yalkowsky, S. H. Enhanced Intestinal Absorption of Cyclosporine in Rats Through the Reduction of Emulsion Droplet Size Pharm. Res. 1989, 6, 40-43
34. Kanicky, J. R.; Shah, D. O. Effect of Degree, Type, and Position of Unsaturation on the pKa of Long-Chain Fatty Acids J. Colloid Interface Sci. 2002, 256, 201-207
35. Owens Iii, D. E.; Peppas, N. A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles Int. J. Pharmaceutics 2006, 307, 93-102
36. Allen, T. M.; Hansen, C. Pharmacokinetics of stealth versus conventional liposomes: effect of dose Biochim. Biophys. Acta Biomembr. 1991, 1068, 133-141
37. Meenach, S. A.; Hilt, J. Z.; Anderson, K. W. Poly(ethylene glycol)-based magnetic hydrogel nanocomposites for hyperthermia cancer therapy Acta Biomater. 2010, 6, 1039-1046
38. Moghimi, S. M.; Szebeni, J. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties Prog. Lipid Res. 2003, 42, 463-478
39. Lakshmana, R. A.; Sankar, G. G. Caco-2 Cells: an overview J. Pharm. Res. Health Care 2009, 1, 260-275
40. Gauthier, M. A.; Simard, P.; Zhang, Z.; Zhu, X. X. Bile acids as constituents for dental composites: in vitro cytotoxicity of (meth)acrylate and other ester derivatives of bile acids J. R. Soc. Interface 2007, 4, 1145-1150
41. Arechabala, B.; Coiffard, C.; Rivalland, P.; Coiffard, L. J. M.; Roeck-Holtzhauer, Y. D. Comparison of cytotoxicity of various surfactants tested on normal human fibroblast cultures using the neutral red test, MTT assay and LDH release J. Appl. Toxicol. 1999, 19, 163-165
42. Kerwin, B. A. Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: Structure and degradation pathways J. Pharm. Sci. 2008, 97, 2924-2935
43. Berliner, F.; Schoenheimer, R. Hemolytic and Antihemolytic Properties of Bile Acids and Sterols in Relation to their Structure J. Biol. Chem. 1938, 124, 525-541
44. Van der Meer, R.; Termont, D. S.; De Vries, H. T. Differential effects of calcium ions and calcium phosphate on cytotoxicity of bile acids Am. J. Physiol. Gastrointest. Liver Physiol. 1991, 260, G142-G147
45. Kameneva, M. V.; Repko, B. M.; Krasik, E. F.; Perricelli, B. C.; Borovetz, H. S. Polyethylene Glycol Additives Reduce Hemolysis in Red Blood Cell Suspensions Exposed to Mechanical Stress ASAIO J. 2003, 49, 537-542
46. Cheon Lee, S.; Kim, C.; Chan Kwon, I.; Chung, H.; Young Jeong, S. Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(ε-caprolactone) copolymer as a carrier for paclitaxel J. Controlled Release 2003, 89, 437-446
47. Shin, J. H.; Choi, K. Y.; Kim, Y. C.; Lee, M. G. Dose-Dependent Pharmacokinetics of Itraconazole after Intravenous or Oral Administration to Rats: Intestinal First-Pass Effect Antimicrob. Agents Chemother. 2004, 48, 1756-1762
48. O'Driscoll, C. M. Lipid-based formulations for intestinal lymphatic delivery Eur. J. Pharm. Sci. 2002, 15, 405-415
49. Humberstone, A. J.; Charman, W. N. Lipid-based vehicles for the oral delivery of poorly water soluble drugs Adv. Drug Delivery Rev. 1997, 25, 103-128
50. Park, M.-J.; Ren, S.; Lee, B.-J. In vitro and in vivo comparative study of itraconazole bioavailability when formulated in highly soluble self-emulsifying system and in solid dispersion Biopharm. Drug Disp. 2007, 28, 199-207
51. Buchanan, C. M.; Buchanan, N. L.; Edgar, K. J.; Klein, S.; Little, J. L.; Ramsey, M. G.; Ruble, K. M.; Wacher, V. J.; Wempe, M. F. Pharmacokinetics of itraconazole after intravenous and oral dosing of itraconazole-cyclodextrin formulations J. Pharm. Sci. 2007, 96, 3100-3116